Suppr超能文献

吸烟对 STEMI 患者直接经皮冠状动脉介入治疗结局的影响。

Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.

机构信息

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Department of Cardiology, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Medical Corps, Israel Defense Forces, Tel Hashomer, Israel; Department of Military Medicine, Hebrew University Hadassah School of Medicine, Jerusalem, Israel.

出版信息

J Am Coll Cardiol. 2020 Apr 21;75(15):1743-1754. doi: 10.1016/j.jacc.2020.02.045.

Abstract

BACKGROUND

Smoking is a well-established risk factor for ST-segment elevation myocardial infarction (STEMI); however, once STEMI occurs, smoking has been associated with favorable short-term outcomes, an observation termed the "smoker's paradox." It has been postulated that smoking might exert protective effects that could reduce infarct size, a strong independent predictor of worse outcomes after STEMI.

OBJECTIVES

The purpose of this study was to determine the relationship among smoking, infarct size, microvascular obstruction (MVO), and adverse outcomes after STEMI.

METHODS

Individual patient-data were pooled from 10 randomized trials of patients with STEMI undergoing primary percutaneous coronary intervention. Infarct size was assessed at median 4 days by either cardiac magnetic resonance imaging or technetium-99m sestamibi single-photon emission computed tomography. Multivariable analysis was used to assess the relationship between smoking, infarct size, and the 1-year rates of death or heart failure (HF) hospitalization and reinfarction.

RESULTS

Among 2,564 patients with STEMI, 1,093 (42.6%) were recent smokers. Smokers were 10 years younger and had fewer comorbidities. Infarct size was similar in smokers and nonsmokers (adjusted difference: 0.0%; 95% confidence interval [CI]: -3.3% to 3.3%; p = 0.99). Nor was the extent of MVO different between smokers and nonsmokers. Smokers had lower crude 1-year rates of all-cause death (1.0% vs. 2.9%; p < 0.001) and death or HF hospitalization (3.3% vs. 5.1%; p = 0.009) with similar rates of reinfarction. After adjustment for age and other risk factors, smokers had a similar 1-year risk of death (adjusted hazard ratio [adjHR]: 0.92; 95% CI: 0.46 to 1.84) and higher risks of death or HF hospitalization (adjHR: 1.49; 95% CI: 1.09 to 2.02) as well as reinfarction (adjHR: 1.97; 95% CI: 1.17 to 3.33).

CONCLUSIONS

In the present large-scale individual patient-data pooled analysis, recent smoking was unrelated to infarct size or MVO, but was associated with a worse prognosis after primary PCI in STEMI. The smoker's paradox may be explained by the younger age and fewer cardiovascular risk factors in smokers compared with nonsmokers.

摘要

背景

吸烟是 ST 段抬高型心肌梗死(STEMI)的一个明确的危险因素;然而,一旦 STEMI 发生,吸烟与短期预后良好有关,这种现象被称为“吸烟者悖论”。据推测,吸烟可能具有保护作用,可以减少梗塞面积,而梗塞面积是 STEMI 后预后较差的一个强有力的独立预测因素。

目的

本研究旨在确定吸烟、梗塞面积、微血管阻塞(MVO)与 STEMI 后不良结局之间的关系。

方法

对 10 项 STEMI 患者行直接经皮冠状动脉介入治疗的随机试验的个体患者数据进行了汇总分析。梗塞面积通过心脏磁共振成像或锝-99m sestamibi 单光子发射计算机断层扫描在中位数为 4 天的时候进行评估。多变量分析用于评估吸烟、梗塞面积与 STEMI 后 1 年的死亡率或心力衰竭(HF)住院率和再梗死率之间的关系。

结果

在 2564 例 STEMI 患者中,1093 例(42.6%)为近期吸烟者。吸烟者比非吸烟者年轻 10 岁,且合并症较少。吸烟者和非吸烟者的梗塞面积相似(校正差异:0.0%;95%置信区间[CI]:-3.3%至 3.3%;p=0.99)。吸烟者和非吸烟者的 MVO 程度也没有差异。吸烟者的 1 年全因死亡率(1.0% vs. 2.9%;p<0.001)和死亡率或 HF 住院率(3.3% vs. 5.1%;p=0.009)较低,但再梗死率相似。调整年龄和其他危险因素后,吸烟者 1 年的死亡风险相似(校正风险比[adjHR]:0.92;95%CI:0.46 至 1.84),死亡率或 HF 住院率(adjHR:1.49;95%CI:1.09 至 2.02)和再梗死率(adjHR:1.97;95%CI:1.17 至 3.33)较高。

结论

在本大规模个体患者数据汇总分析中,近期吸烟与梗塞面积或 MVO 无关,但与 STEMI 患者行直接经皮冠状动脉介入治疗后的预后较差有关。吸烟者悖论可能是由于与非吸烟者相比,吸烟者年龄较小,心血管危险因素较少。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验